{
  "case_id": "Case_11",
  "model_id": "liquid/lfm-40b",
  "content": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Acute Hemolysis due to G6PD Deficiency Induced by Semaglutide\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"D55.1\",\n        \"reasoning\": \"Patient's symptoms and recent semaglutide use suggest a possible drug-induced hemolytic anemia, particularly given the ethnic background and potential for G6PD deficiency.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Hepatitis\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"B17.9\",\n            \"reasoning\": \"Jaundice and fatigue can be symptoms of hepatitis, though the rapid heart rate and shortness of breath are atypical for this diagnosis.\"\n        },\n        {\n            \"name\": \"Autoimmune Hemolytic Anemia\",\n            \"confidence\": 0.7,\n            \"icd_code\": \"D59.0\",\n            \"reasoning\": \"The patient's symptoms, especially fatigue and tachycardia, could be consistent with autoimmune hemolysis, but the ethnic background suggests G6PD deficiency is also a possibility.\"\n        },\n        {\n            \"name\": \"Drug-Induced Hemolytic Anemia\",\n            \"confidence\": 0.85,\n            \"icd_code\": \"D59.1\",\n            \"reasoning\": \"The recent introduction of semaglutide and the patient's symptoms strongly suggest a drug-induced hemolytic anemia, especially given the absence of other chronic conditions.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Jaundice\",\n        \"Rapid heart rate\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Complete Blood Count (CBC)\",\n            \"purpose\": \"Detect anemia and other blood cell abnormalities\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Haptoglobin\",\n            \"purpose\": \"Confirm extent of hemolysis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"G6PD Test\",\n            \"purpose\": \"Confirm G6PD deficiency\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Discontinue semaglutide\",\n            \"Administer intravenous fluids\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Folic Acid\",\n                \"dose\": \"1 mg PO once daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Until further notice\",\n                \"rationale\": \"Treat anemia and support erythropoiesis\"\n            }\n        ],\n        \"monitoring\": [\n            \"CBC, LFTs, and hemolysis markers\",\n            \"Daily until stable, then weekly\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Hematology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For further management and consultation on specific therapies\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Hypoxia (if present)\",\n        \"Severe anemia requiring blood transfusion\"\n    ],\n    \"patient_education\": [\n        \"Avoid triggers of hemolysis\",\n        \"Monitor for worsening symptoms\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"1 week after initial treatment\",\n        \"conditions\": \"Return immediately if symptoms worsen\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Extent of liver involvement\",\n        \"Response to discontinuation of semaglutide\"\n    ]\n}\n```",
  "latency": 6.171589136123657,
  "timestamp": "2025-08-10T01:33:09.514180",
  "cached_at": "2025-08-10T01:33:09.514184"
}